iCellate develops and provides cancer profiling services for precision oncology. iCellate’s CellMate® is a next generation circulating tumor cell (CTC)-based platform for cancer cell detection and comprehensive biomarker analysis. GeneMate® is an analysis for hereditary cancer and gBRCA testing.
Medical and Diagnostic Laboratories, Pathological and clinical laboratories, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Scientific Research and Development Services, Services